A carregar...
Ipilimumab: from preclinical development to future clinical perspectives in melanoma
The arsenal for the treatment of metastatic melanoma is limited. A new approach to therapy using checkpoint blockade has improved overall survival in this patient population. Ipilimumab a CTLA-4 monoclonal antibody is a first in class drug that has pioneered this revolution. In this review, the auth...
Na minha lista:
| Publicado no: | Future Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5618953/ https://ncbi.nlm.nih.gov/pubmed/27882779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon-2016-0385 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|